Concepedia

Kendall Wu

KW

Statistics

Publications

6

Citations

699

H-Index

6

Active since

2002

Affiliations

Baylor College of Medicine(Current)

Ligand Pharmaceuticals (United States)

The University of Texas MD Anderson Cancer Center

Kendall Wu is an author at Baylor College of Medicine specializing in medicine, oncology, and retinoid receptors.

Publications per year

2002–2008

6

Publications

6

An elt-3/elt-5/elt-6 GATA Transcription Circuit Guides Aging in C. elegans

Yelena V. Budovskaya, Kendall Wu, Lucinda K. Southworth et al. · Cell · 2008 · 263 citations · Full text

Life Sciences, Genetics, Molecular Genetics +4

The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice.

Kendall Wu, Yun Zhang, Xiao Xu et al. · PubMed · 2002 · 159 citations

Medicine, Oncology, Pharmacology +10

Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.

Kendall Wu, Hee-Tae Kim, Jenny L Rodriquez et al. · PubMed · 2002 · 143 citations

Medicine, Cancer Biology, Oncology +14

The Retinoid X Receptor-Selective Retinoid, LGD1069, Down-regulates Cyclooxygenase-2 Expression in Human Breast Cells through Transcription Factor Crosstalk: Implications for Molecular-Based Chemoprevention

Gu Kong, Hee-Tae Kim, Kendall Wu et al. · Cancer Research · 2005 · 62 citations

Medicine, Oncology, Pharmacology +13

Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade

Kendall Wu, Elizabeth Dupre, Heetae Kim et al. · Breast Cancer Research and Treatment · 2005 · 40 citations

Medicine, Oncology, Pharmacology +16

1–5 of 6